First detection of CTX-M-28 in a Tunisian hospital from a cefotaxime-resistant Klebsiella pneumoniae strain

Pathologie Biologie

Volumn 57, Issue 5, 2009, Pages 343-348

  Ben Achour, N ^a   Mercuri, P S ^b   Power, P ^b   Belhadj, C ^a   Ben Moussa, M ^c   Galleni, M ^b   Belhadj, O ^a  

^a FACULTÉ DES SCIENCES DE TUNIS   (Tunisia)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c MILITARY HOSPITAL OF TUNIS   (Tunisia)

Author keywords

Cephalosporins; CTX M; ESBL; lactamases

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFALORIDINE; CEFOTAXIME; CEFOXITIN; CEFPIROME; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; NALIDIXIC ACID; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; TETRACYCLINE DERIVATIVE; TICARCILLIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; HUMAN; INTENSIVE CARE UNIT; ISOELECTRIC FOCUSING; KLEBSIELLA PNEUMONIAE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; POLYMERASE CHAIN REACTION; PUBLIC HOSPITAL; TUNISIA;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CEFOTAXIME; CROSS INFECTION; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HOSPITALS, MILITARY; HUMANS; INTENSIVE CARE UNITS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; R FACTORS; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, AMINO ACID; TUNISIA;

EID: 67649233712     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2008.07.016     Document Type: Article

References (36)

1. Eckert C., Gautier V., Saladin-Allard M., Hidri N., Verdet C., Ould-Hocine Z., et al. Dissemination of CTX-M-Type β-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob Agents Chemother 48 (2004) 1249-1255
2. Pieboji J.G., Miriagou V., Vourli S., Tzelepi E., Ngassam P., and Tzouvelekis L.S. Emergence of CTX-M-15-producing enterobacteria in Cameroon and characterization of a blaCTX-M-15-carrying element. Antimicrob Agents Chemother 49 (2005) 441-443
3. Bonnet R. Growing croup of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 48 (2004) 1-14
4. Mena A., Plasencia V., Garci{dotless}a L., Hidalgo O., Ayestaran J.I., Alberti S., et al. Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development. J Clin Microbiol 44 (2006) 2831-2837
5. Hernandez J.R., Marti{dotless}nez-Marti{dotless}nez L., Canton R., Coque T.M., Pascual A., and the Spanish Group for Nosocomial Infections (GEIH). Nationwide study of Escherichia coli and Klebsiella pneumonia producing extended-spectrum β-lactamases in Spain. Antimicrob Agents Chemother 49 (2005) 2122-2125
6. Oliver A., Coque T.M., Alonso D., Valverde A., Baquero F., and Canton R. CTX-M-10 linked to a phage-related element is widely disseminated among Enterobacteriaceae in a Spanish hospital. Antimicrob Agents Chemother 49 (2005) 1567-1571
7. Quinteros M., Radice M., Gardella N., Rodriguez M.M., Costa N., Korbenfeld D., et al. Extended-spectrum β-lactamases in Enterobacteriaceae in Buenos Aires, Argentina, public hospitals. Antimicrob Agents Chemother 47 (2003) 2864-2867
8. Tumbarello M., Spanu T., Sanguinetti M., Citton R., Montuori E., Leone F., et al. Bloodstream infections caused by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome. Antimicrob Agents Chemother 50 (2006) 498-504
9. Radice M., Power P., Di Conza J., and Gutkind G. Early dissemination of CTX-M-derived enzymes in South America. Antimicrob Agents Chemother 46 (2002) 602-604
10. Munday C.J., Boyd D.A., Brenwald N., Miller M., Andrews J.M., Wise R., et al. Molecular and kinetic comparison of the novel extended-spectrum β-Lactamases CTX-M-25 and CTX-M-26. Antimicrob Agents Chemother 48 (2004) 4829-4834
11. Humeniuk C., Guillaume A., Gautier V., Grimont P., Labia R., and Philippon A. β-lactamases of Kluyvera ascorbata, probable progenitors of some plasmid-encoded CTX-M types. Antimicrob Agents Chemother 46 (2002) 3045-3049
12. Poirel L., Kämpfer P., and Nordmann P. Chromosome-encoded ambler class A β-lactamase of Kluyvera georgiana, a probable progenitor of a subgroup of CTX-M extended-spectrum β-lactamases. Antimicrob Agents Chemother 46 (2002) 4038-4040
13. Olson A.B., Silverman M., Boyd D.A., McGeer A., Willey B.M., Porter V.P., et al. Identification of a progenitor of the CTX-M-9 Group of extended-spectrum β-lactamases from Kluyvera georgiana isolated in Guyana. Antimicrob Agents Chemother 49 (2005) 2112-2115
14. Rodríguez M.M., Power P., Radice M., Vay C., Famiglietti A., Galleni M., et al. Chromosome-encoded CTX-M-3 from Kluyvera ascorbata: a possible origin of plasmid-borne CTX-M-1-derived cefotaximases. Antimicrob Agents Chemother 48 (2004) 4895-4897
15. Ben Boubaker B., Ghozzi I.R., Ben Abdallah H., Mamlouk K., Kamoun A., and Ben Redjeb S. Evolution of acquired-resistance to third-generation cephalosporins in Enterobacteriaceae in a Tunisian hospital 1993-2001. Clin Microbiol Infect 10 (2004) 665-667
16. Mamlouk K., Ben Boubaker I.B., Gautier V., Vimont S., Picard B., Ben Redjeb S., et al. Emergence and outbreaks of CTX-M β-lactamase-producing Escherichia coli and Klebsiella pneumoniae strains in a Tunisian hospital. J Clin Microbiol 44 (2006) 4049-4056
17. Armand-Lefevre L., Leflon- Guibout V., Bredin J., Barguellil F., Amor A., et al. Imipenem resistance in Salmonella enterica serovar Wien related to porin loss and CMY-4 β-lactamase production. Antimicrob Agents Chemother 47 (2003) 1165-1168
18. Bouallègue-Godet O., Ben Salem Y., Fabre L., Demartin M., Grimont P.A., Mzoughi R., et al. Nosocomial outbreak caused by Salmonella enterica serotype Livingstone producing CTX-M-27 extended-spectrum β-lactamase in a neonatal unit in Sousse, Tunisia. J Clin Microbiol 43 (2005) 1037-1044
19. Ktari S., Arlet G., Mnif B., Gautier V., Mahjoubi F., Ben Jmeaa M., et al. Emergence of multidrug-resistant Klebsiella pneumoniae isolates producing VIM-4 Metallo-β-lactamase, CTX-M-15 extended-spectrum β-lactamase, and CMY-4 AmpC β-lactamase in a Tunisian university hospital. Antimicrob Agents Chemother 50 (2006) 4198-4201
20. Clinical and laboratory standards institute. Performance standards for antimicrobial susceptibility testing; sixteenth informational supplement, CLSI document M100-S16. Wayne, PA:CLSI;2006.
21. Jacoby G.A., and Han P. Detection of extended-spectrum β-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol 34 (1996) 908-911
22. Livermore D.M., Brawn D.F.J., Belhadj C., and Belhadj O. Detection of b-lactamase-mediated resistance. J Antimicrob Chemother 48 (2001) SI: 59-64
23. Ben-Mahrez K., Réjiba S., Belhadj C., and Belhadj O. β-lactamase-mediated resistance to extended spectrum cephalosporins among clinical isolates of Pseudomonas aeruginosa. Res Microbiol 150 (1999) 403-406
24. Labia R., and Barthélémy M. Beta-lactamase enzymogram: an agar adaptation of the iodometric method. Ann Microbiol 30B 3 (1979) 295-304
25. Perret C.J. Iodometric assay of penicillinases. Nature 174 (1954) 1012-1013
26. Asensio A., Oliver A., Gonzalez-Diego P., Baquero F., Perez-Diaz J.C., Ros P., et al. Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: antibiotic use as a risk factor for colonization and infection. Clin Infect Dis 30 (2000) 55-60
27. Bradford P.A. Extended spectrum β-lactamases in the 21st century: characterisation, epidemiology, and detection of this important resistance threat. Clin Microbilol Rev 14 (2001) 933-951
28. Kang C.I., Kim S.H., Park W.B., Lee K.D., Kim H.B., Kim E.C., et al. Bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy. Antimicrob Agents Chemother 48 (2004) 4574-4581
29. Nathisuwan S., Burgess D.S., and Lewis J.S. Extended spectrum β-lactamases: epidemiology, detection and treatment. Pharmacotherapy 21 (2001) 920-928
30. Rice L., Eckstein E.C., De Vente J., and Shlaes D.M. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland department of Veterans affairs medical center. Clin Infect Dis 23 (1996) 118-124
31. Shannon K., Stapleton P., Xiang X., Johnson A., Beattie H., El Bakri F., et al. Extended-spectrum β-lactamase-producing Klebsiella pneumoniae strains causing nosocomial outbreaks of infection in the United Kingdom. J Clin Microbiol 36 (1998) 3105-3110
32. Ambler R.P., Coulson A.F.W., Frere J.M., Ghuysen J.M., Joris B., Forsman M., et al. A standard numbering scheme for the class A β-lactamases. Biochem J 276 (1991) 269-270
33. Bonnet R., Dutour C., Sampaio J.L.M., Chanal C., Sirot D., Labia R., et al. Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp240Gly. Antimicrob Agents Chemother 45 (2001) 2269-2275
34. Bonnet R., Recule C., Baraduc R., Chanal C., Sirot D., De Champs C., et al. Effect of D240G substitution in a novel ESBL CTX-M-27. J Antimicrob Chemother 52 (2003) 29-35
35. Poirel L., Gniadkowski M., and Nordmann P. Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum beta-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-3. J Antimicrob Chemother 50 (2002) 1031-1034
36. Sturenburg E., Kuhn A., Mack D., and Laufs R. A novel extended-spectrum β-lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistance. J Antimicrob Chemother 54 (2004) 406-409